Not A Member?       Forget Password?     
          Click HERE                   Click HERE
   and Register FREE
   LATEST INTERVIEWS
09/05/2008
-
Alternate Energy Holdings, Inc.
( OTCBB:AEHI ) / Donald Gillispie
 
09/05/2008
-
Cardiovascular Sciences, Inc.
( OTC:CVSC ) / Dr. Larry Hooper
 
09/04/2008
-
Atna Resources
( TSX:ATN ) / Jim Hesketh
 
08/28/2008
-
PacificHealth Laboratories, Inc.
( OTCBB:PHLI ) / Jason Ash
 
08/26/2008
-
Dynamic Response Group, Inc.
( OTCBB:DRGP ) / Melissa Rice
 
08/26/2008
-
Ever-Glory International Group, Inc.
( AMX:EVK ) / Edward Kang
 
08/26/2008
-
Boveran Diagnostics, Inc.
( OTCBB:BOVD ) / Anthony Welch
 
08/15/2008
-
Columbus Gold Corp.
( OTC:CBGDF ) / Robert Giustra
 
08/14/2008
-
Bonds.com Group Inc
( OTCBB:BDCG ) / John Barry IV
 
 
   CEOcast WEEKLY NEWSLETTER  
  
September 8th CEOcast Weekly Newsletter
VOLUME 368 Companies featured in the current edition of the newsletter: CBMC, CETG, CLXS, CVM, ETGF, GMPM, GNBT, GSPG, IASCA, ICLK, NSMG, SRRY Despite the holiday-shortened week, the markets remained ... Click here for more...
 
   
   STOCKS ON THE MOVE  

GoldSpring, Inc
 

GoldSpring Releases Assay Results Which Demonstrate Continuation of Favorable Indications From Drill Program
GoldSpring, Inc. reported today a continuation in the trend of encouraging assay results from its latest four drill holes, numbered 45-48, suggesting expanded depth and surface area of the identified ore body in the Hartford Complex. The Hartford Complex represents less than five percent of the Company's total leases of landholdings in the Comstock Lode."The assays from drill holes 45-48 continue the trend of favorable indications from our 2008 drilling program, suggesting the potential for a broader range of mineralization," said Jim Golden, GoldSpring's Chief Operating Officer......

 
Vyteris Inc
 

Vyteris, Inc. Receives $2.5 Million Loan from Ferring Pharmaceuticals, Inc.
Vyteris, Inc. manufacturer of the first FDA-approved active patch transdermal drug delivery system, received $2.5 million principal amount of financing effective on July 9, 2008 from Ferring Pharmaceuticals, Inc. (Ferring), which represented an advance on a potential milestone payment for a Phase II clinical trial of a product for female fertility treatment. The $2.5 million was advanced in the form of a loan and bears interest at the rate of 10 percent per annum. If Ferring elects to proceed with the Phase II trial, the principal amount of the loan will be paid off through application of the Phase II payment which would otherwise be due under the License Agreement between Vyteris and Ferring....

 

 
i2 Telecom International
 

i2Telecom International Announces Second Quarter Results
i2Telecom International, Inc. a developer of award-winning patented and innovative high-quality Voice-over-Internet Protocol (VoIP) products and services, announced today record second quarter results for the period ended June 30, 2008. I am pleased to report the first profitable quarter in the Companys history, said Mr. Arena. We believe there is considerable interest in our technology both domestically and internationally, and feel i2Telecom has reached an inflection point where the people, distribution network and technology are now in place to drive rapid revenue growth. We are excited about our prospects for future growth, which is why the Company expects revenue from the sale of VOIP products and related services to increase by more than 400% this year.....

 

 
     
 
 
Copyright © 2001-2005. All Rights Reserved. Disclaimer | Privacy Policy